|

Placebo for infusions Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 0.9% Sodium chloride

Pipeline

Phase 2: 1

Top Sponsors

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Indications

  • Acute Liver Injury1
  • Fulminant Hepatic Failure1
  • Acute Liver Failure1
  • Liver Disease1
  • Hepatic Encephalopathy1

Los Angeles, California1 trial

TReatment for ImmUne Mediated PathopHysiology

Children's Hospital Los Angeles

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.